» Articles » PMID: 28642732

Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson's Disease

Overview
Journal Front Neurol
Specialty Neurology
Date 2017 Jun 24
PMID 28642732
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Autonomic disorders have been recognized as important Parkinson's disease (PD) components. Some vulnerable structures are related to the central autonomic network and have also been linked to autonomic function alterations. The aims of the study are to evaluate the severity of the autonomic dysfunction and the cortical hypoperfusion using arterial spin labeling (ASL) MRI. And then, possible relationships of significant between-group differences in perfusion pattern to clinical variables and autonomic functions were examined to determine the pharmaceutical effects of dopaminergic treatment on cerebral blood flow (CBF) in patients with PD.

Methods: Brain ASL MRI was carried out in 20 patients with PD (6 men and 14 women, mean age: 63.3 ± 6.4 years) and 22 sex- and age-matched healthy volunteers to assess whole-brain CBF and the effects of dopaminergic therapy on perfusion. All subjects underwent a standardized evaluation of cardiovagal and adrenergic function including a deep breathing, Valsalva maneuver, and 5-min head-up tilt test. Perfusion MRI data were acquired on a 3.0 T scanner with a pulsed continuous ASL technique. The CBF, autonomic parameters, and clinical data were analyzed after adjusting for age and sex.

Results: Patients exhibited a decline in autonomic function (rapid heart rate in response to deep breathing, low baroreflex sensitivity, high systolic and diastolic pressure, and altered tilting test response), widespread low CBF, and robust response to dopaminergic therapy. Lower perfusion in the middle frontal gyrus was associated with increased clinical disease severity (Unified Parkinson's Disease Rating Scale I score,  < 0.001). Lower perfusion in autonomic control areas, such as the frontal lobe and insula, were significantly associated with autonomic impairment ( < 0.001).

Conclusions: Our study indicates that PD is a progressive neurodegenerative disorder that changes the perfusion of central nervous system and is associated with variable autonomic dysfunctions. Neuronal loss and sympathetic activation may explain the interaction between cortical autonomic region perfusion and cardiovascular autonomic function.

Citing Articles

Clinically probable RBD is an early predictor of malignant non-motor Parkinson's disease phenotypes.

Martinez-Nunez A, Hutchinson H, Coutinho P, Sarmento F, Srikar Lavu V, Yuan Q NPJ Parkinsons Dis. 2025; 11(1):25.

PMID: 39875387 PMC: 11775280. DOI: 10.1038/s41531-025-00874-8.


Baroreflex Sensitivity as a Surrogate Biomarker for Concurrently Assessing the Severity of Arterial Stiffness and Cardiovascular Autonomic Neuropathy in Individuals with Type 2 Diabetes.

Hsieh D, Lai Y, Huang C, Chen Y, Wu S, Chiu W J Pers Med. 2024; 14(5).

PMID: 38793073 PMC: 11122369. DOI: 10.3390/jpm14050491.


Synchronous monitoring of brain-heart electrophysiology using heart rate variability coupled with rapid quantitative electroencephalography in orthostatic hypotension patients with α-synucleinopathies: Rapid prediction of orthostatic hypotension and....

Lin L, Cheng Y, Huang P, Zhang J, Zheng J, Pan X CNS Neurosci Ther. 2024; 30(2):e14571.

PMID: 38421092 PMC: 10850923. DOI: 10.1111/cns.14571.


Abnormalities of cerebral blood flow and the regional brain function in Parkinson's disease: a systematic review and multimodal neuroimaging meta-analysis.

Xie H, Yang Y, Sun Q, Li Z, Ni M, Chen Z Front Neurol. 2024; 14:1289934.

PMID: 38162449 PMC: 10755479. DOI: 10.3389/fneur.2023.1289934.


Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease.

Matt R, Martin R, Evans A, Gever J, Vargas G, Shamloo M Handb Exp Pharmacol. 2023; 285:555-616.

PMID: 37495851 DOI: 10.1007/164_2023_677.


References
1.
Kamagata K, Motoi Y, Hori M, Suzuki M, Nakanishi A, Shimoji K . Posterior hypoperfusion in Parkinson's disease with and without dementia measured with arterial spin labeling MRI. J Magn Reson Imaging. 2011; 33(4):803-7. DOI: 10.1002/jmri.22515. View

2.
Hughes A, Daniel S, Kilford L, Lees A . Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55(3):181-4. PMC: 1014720. DOI: 10.1136/jnnp.55.3.181. View

3.
Kelly C, de Zubicaray G, Di Martino A, Copland D, Reiss P, Klein D . L-dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study. J Neurosci. 2009; 29(22):7364-78. PMC: 2928147. DOI: 10.1523/JNEUROSCI.0810-09.2009. View

4.
Lin W, Chou K, Lee P, Huang Y, Tsai N, Chen H . Brain mediators of systemic oxidative stress on perceptual impairments in Parkinson's disease. J Transl Med. 2015; 13:386. PMC: 4687285. DOI: 10.1186/s12967-015-0749-9. View

5.
Low P . Testing the autonomic nervous system. Semin Neurol. 2004; 23(4):407-21. DOI: 10.1055/s-2004-817725. View